Cinnarizine D8
(Synonyms: 桂利嗪 D8) 目录号 : GC60709
An internal standard for the quantification of cinnarizine
Cas No.:1185242-27-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cinnarizine-d8 is intended for use as an internal standard for the quantification of cinnarizine by GC- or LC-MS. Cinnarizine is a calcium channel inhibitor and histamine H4 receptor antagonist (Ki = 142 nM).1,2,3 It inhibits L- and T-type calcium channels in isolated guinea pig atrial cells in a voltage-dependent manner.1 Cinnarizine inhibits L-type calcium currents in isolated guinea pig type II vestibular hair cells (IC50 = 1.5 ?M). In vivo, cinnarizine (10 mg/kg) inhibits ethanol-induced gastric ulcer formation in rats.4 Formulations containing cinnarizine have been used in the treatment of nausea and vomiting due to vertigo, Meniere's disease, or chemotherapy.
1.Cohen, C.J., Spires, S., and Van Skiver, D.Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonistsJ. Gen. Physiol.100(4)703-728(1992) 2.Arab, S.F., Düwel, P., Jüngling, E., et al.Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizineNaunyn Schmiedebergs Arch. Pharmacol.369(6)570-575(2004) 3.Nguyen, T., Shapiro, D.A., George, S.R., et al.Discovery of a novel member of the histamine receptor familyMol. Pharmacol.59(3)427-433(2001) 4.Lozeva, V., Marazova, K., and Belcheva, A.Gastric histamine content and ulcer formation in rats with ethanol-induced injury. Effects of cinnarizine and flunarizineAgents Actions41 Spec NoC91-C92(1994)
| Cas No. | 1185242-27-6 | SDF | |
| 别名 | 桂利嗪 D8 | ||
| Canonical SMILES | [2H]C1([2H])C([2H])([2H])N(C/C=C/C2=CC=CC=C2)C([2H])([2H])C([2H])([2H])N1C(C3=CC=CC=C3)C4=CC=CC=C4 | ||
| 分子式 | C26H20D8N2 | 分子量 | 376.56 |
| 溶解度 | DMSO : 7.14 mg/mL (18.96 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6556 mL | 13.2781 mL | 26.5562 mL |
| 5 mM | 0.5311 mL | 2.6556 mL | 5.3112 mL |
| 10 mM | 0.2656 mL | 1.3278 mL | 2.6556 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet